ABSTRACT
With the possible exception of melanomas that arise within or around the eye, malignancies of the lacrimal gland arguably are the most deadly tumors that an ophthalmologist may encounter in clinical practice. As with most cancers, survival is improved with early detection, and early detection is more likely when the practitioner is prepared to recognize and follow-up signs and symptoms that may be relatively subtle. In this short review, I will pose a series of questions that the ophthalmologist should be considering when he or she is examining a patient with a possible lacrimal gland malignancy.
